
John Isacson
Professional Bio
A registered patent attorney, John has particular experience in strategic counseling and patent portfolio management, infringement litigation, due diligence, inter partes and post-grant reviews, reexaminations, patent interferences, inventorship and ownership disputes, biosimilars, and Hatch-Waxman. He is regularly involved in litigation and U.S. Patent and Trademark Office proceedings. John also advises on related FDA matters for certain technologies.
Inter Partes Review of Pre-AIA Patents is Constitutional
PostGrant-Counsel Blog ·
Updated Procedures at the Patent Trial and Appeal Board
PostGrant-Counsel Blog ·
Neptune Generics, LLC v. Eli Lilly & Co., No. 2018-1257 (Fed. Cir. Apr. 26, 2019).
PostGrant-Counsel Blog ·
Recent Proposal for Section 101 Reform
PostGrant-Counsel Blog ·